Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kyne

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Gut|June 20, 2001
Recurrent Clostridium difficile diarrhoeaL Kyne, C P Kelly
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Prospects for a vaccine for Clostridium difficileL Kyne, C P Kelly
Journal of Medical Microbiology|March 23, 2013
Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failureP Moore, L Kyne, A Martin, et al.
Gastroenterology Clinics of North America|October 6, 2001
Clostridium difficileL Kyne, R J Farrell, C P Kelly
The New England Journal of Medicine|February 10, 2000
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin AL Kyne, M Warny, A Qamar, et al.
Lancet (London, England)|February 24, 2001
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoeaL Kyne, M Warny, A Qamar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 30, 2007
Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, IrelandD Drudy, N Harnedy, S Fanning, et al.
The Journal of Hospital Infection|March 1, 1996
Diagnostic value of Clostridium difficile cytotoxin assayL Kyne, C Merry, B O'Connell, et al.
The Journal of Infection|November 20, 1998
Community-acquired Clostridium difficile infectionL Kyne, C Merry, B O'Connell, et al.
Aging (Milan, Italy)|May 25, 1999
Is age a negative prognostic indicator in HIV infection or AIDS?M J Keller, J M Hausdorff, L Kyne, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Gut|June 20, 2001
Recurrent Clostridium difficile diarrhoeaL Kyne, C P Kelly
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Prospects for a vaccine for Clostridium difficileL Kyne, C P Kelly
Journal of Medical Microbiology|March 23, 2013
Germination efficiency of clinical Clostridium difficile spores and correlation with ribotype, disease severity and therapy failureP Moore, L Kyne, A Martin, et al.
Gastroenterology Clinics of North America|October 6, 2001
Clostridium difficileL Kyne, R J Farrell, C P Kelly
The New England Journal of Medicine|February 10, 2000
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin AL Kyne, M Warny, A Qamar, et al.
Lancet (London, England)|February 24, 2001
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoeaL Kyne, M Warny, A Qamar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 30, 2007
Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, IrelandD Drudy, N Harnedy, S Fanning, et al.
The Journal of Hospital Infection|March 1, 1996
Diagnostic value of Clostridium difficile cytotoxin assayL Kyne, C Merry, B O'Connell, et al.
The Journal of Infection|November 20, 1998
Community-acquired Clostridium difficile infectionL Kyne, C Merry, B O'Connell, et al.
Aging (Milan, Italy)|May 25, 1999
Is age a negative prognostic indicator in HIV infection or AIDS?M J Keller, J M Hausdorff, L Kyne, et al.
Pageof 3